🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/09/2003 | 52,29 | 52,70 | 51,09 | 51,77 | -0,22% | 3,08% | 340.584 |
| 18/09/2003 | 53,90 | 53,97 | 51,65 | 51,88 | -3,68% | 4,31% | 473.125 |
| 17/09/2003 | 54,05 | 54,80 | 52,55 | 53,86 | -0,90% | 4,16% | 236.549 |
| 16/09/2003 | 53,52 | 55,51 | 53,15 | 54,35 | -1,43% | 4,41% | 259.045 |
| 15/09/2003 | 53,71 | 56,07 | 53,71 | 55,13 | +2,22% | 4,39% | 101.176 |
| 12/09/2003 | 54,61 | 54,87 | 51,54 | 53,94 | -1,84% | 6,10% | 293.830 |
| 11/09/2003 | 53,90 | 54,95 | 53,52 | 54,95 | +1,45% | 2,64% | 105.985 |
| 10/09/2003 | 56,14 | 56,37 | 53,37 | 54,16 | -4,61% | 5,33% | 336.309 |
| 09/09/2003 | 57,64 | 58,02 | 56,14 | 56,78 | -1,30% | 3,25% | 181.941 |
| 08/09/2003 | 56,33 | 57,64 | 55,88 | 57,53 | +1,92% | 3,12% | 187.631 |
| 05/09/2003 | 56,14 | 56,82 | 52,48 | 56,44 | -0,13% | 7,73% | 144.217 |
| 04/09/2003 | 54,57 | 56,59 | 53,79 | 56,52 | +4,07% | 5,14% | 197.035 |
| 03/09/2003 | 53,97 | 54,65 | 53,71 | 54,31 | +0,97% | 1,73% | 94.951 |
| 02/09/2003 | 51,20 | 53,90 | 51,13 | 53,79 | +3,75% | 5,41% | 230.752 |
| 29/08/2003 | 51,77 | 52,29 | 50,64 | 51,84 | +0,58% | 3,18% | 95.646 |
| 28/08/2003 | 50,72 | 52,33 | 49,78 | 51,54 | +1,62% | 5,02% | 226.958 |
| 27/08/2003 | 50,27 | 51,65 | 49,82 | 50,72 | +0,52% | 3,65% | 223.993 |
| 26/08/2003 | 50,01 | 51,17 | 49,59 | 50,46 | -1,61% | 3,14% | 158.270 |
| 25/08/2003 | 50,90 | 51,80 | 50,46 | 51,28 | +2,47% | 2,65% | 82.929 |
| 22/08/2003 | 51,28 | 52,40 | 49,11 | 50,04 | -2,55% | 6,42% | 112.023 |
| 21/08/2003 | 50,90 | 51,95 | 50,49 | 51,35 | +1,11% | 2,87% | 321.241 |
| 20/08/2003 | 50,19 | 50,90 | 49,82 | 50,79 | +1,19% | 2,16% | 83.970 |
| 19/08/2003 | 50,34 | 52,21 | 49,59 | 50,19 | +0,30% | 5,20% | 246.755 |
| 18/08/2003 | 46,68 | 50,16 | 46,41 | 50,04 | +7,82% | 8,02% | 292.948 |
| 15/08/2003 | 45,48 | 46,97 | 45,48 | 46,41 | +1,14% | 3,29% | 44.617 |
| 14/08/2003 | 45,48 | 47,09 | 44,88 | 45,89 | +1,41% | 4,86% | 82.688 |
| 13/08/2003 | 46,04 | 46,04 | 44,92 | 45,25 | -0,82% | 2,44% | 91.024 |
| 12/08/2003 | 42,97 | 46,15 | 42,67 | 45,63 | +6,09% | 8,10% | 286.723 |
| 11/08/2003 | 43,04 | 44,35 | 42,41 | 43,01 | -0,09% | 4,52% | 217.394 |
| 08/08/2003 | 42,48 | 44,73 | 41,17 | 43,04 | +2,22% | 8,37% | 204.409 |